TABLE 2

Bupropion and its hydroxy metabolites as functional antagonists toward nAChR subtypes in cell lines

86Rb+ efflux assays were conducted as described under Materials and Methods and in the legend to Fig. 1. Results were fit to the logistic equation to determine molar IC50 values and Hill coefficients (values given in parentheses) presented as ± S.E.M.

SH-SY5Y α3β4* SH-EP1-hα4β2α4β2 SH-EP1-hα4β4α4β4 TE671/RD α1*
μM
Bupropion 1.8 ± 1.1a,b (-1.24 ± 0.19) 12 ± 1.1b (-1.24 ± 0.18) 14 ± 1.1b (-1.19 ± 0.09) 7.9 ± 1.1b (-1.25 ± 0.14)
(2S,3S) OH-bupropion 10 ± 1.5 (-1.08 ± 0.35) 3.3 ± 1.1a,c (-1.31 ± 0.11) 30 ± 1.1c (-1.10 ± 0.12) 28 ± 1.4 (-1.25 ± 0.32)
(2R,3R)-OH-bupropion 6.5 ± 1.2a,b (-1.08 ± 0.18) 31 ± 1.1 (-1.53 ± 0.27) 41 ± 1.1c (-1.65 ± 0.19) 7.6 ± 1.1a,b (-1.23 ± 0.13)
  • a P < 0.05 relative to other subtypes for the indicated drug.

  • b P < 0.05 within subtype relative to (2S, 3S)-hydroxybupropion.

  • c P < 0.05 within subtype relative to bupropion.